Commonwealth Equity Services
IRWD icon

Commonwealth Equity Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Commonwealth Equity Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
25,478
-1,000
-4% -$3.85K ﹤0.01% 4244
2026
Q1 		$92.9K Hold
26,478
– – ﹤0.01% 4146
2025
Q4 		$89.2K Buy
+26,478
New +$68.8K ﹤0.01% 4126

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Commonwealth Equity Services's IRWD Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Ironwood Pharmaceuticals (IRWD) stake by 3.8% in Q2 2026, selling an estimated $3.85K and leaving 25,478 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #4244.

Commonwealth Equity Services first reported a position in IRWD in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Commonwealth Equity Services held 25,478 shares of Ironwood Pharmaceuticals worth $107K as of Q2 2026.
  • Commonwealth Equity Services sold 1,000 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $3.85K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4244 holding.
  • Commonwealth Equity Services first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.